Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.063 | 0.9706 | 0.9706 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.064 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.063 | 0.9706 | 0.9604 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.064 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0378 | 0.2852 | 0.5 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0378 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.064 | 1 | 1 |
Schistosoma mansoni | 6-phosphofructokinase | 0.064 | 1 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0378 | 0.2852 | 0.5 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0378 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.064 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0378 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.063 | 0.9706 | 0.9706 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.063 | 0.9706 | 0.9706 |
Loa Loa (eye worm) | hypothetical protein | 0.064 | 1 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.064 | 1 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.063 | 0.9706 | 0.9706 |
Onchocerca volvulus | 0.064 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 23.4 uM | Antagonist activity at rabbit CaV1.2alpha1C transfected in HEK293 cells by FLIPR assay | ChEMBL. | 23651412 |
IC50 (binding) | = 38.6 uM | Antagonist activity at rat CaV1.3alpha1D transfected in HEK293 cells by FLIPR assay | ChEMBL. | 23651412 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.